2007年中国OTC市场研究报告

报告编号：0237850　　繁体中文　　字号：大中小　　下载简版

名　称：2007年中国OTC市场研究报告
编　号：0237850←咨询时，请说明该编号。
市场价：电子版15000元　　
优惠价：电子版13500元　　纸质+电子版13800元可提供增值税专用发票
电　话：400-612-8668、010-66181099、66182099、66183099
邮　箱：kf@20087.com　　下载《订购协议》
提　示：如需英文版、日文版等其他语言版本，请向客服咨询。
网上订购　下载协议　下载简版

内容介绍：

相
关
报
告

	中国OTC市场研究分析与发展趋势预测报告（2024-2030年）优惠价：7200元
	中国OTC产业市场深度研究分析报告（2024年版）优惠价：7200元

　　1 CHINA’S OTC PHARMACEUTICALS MARKET

　　1.1 Overview

　　1.2 China’s Total Non-food Market

　　1.2.1 Total Non-food Market： Food and Non-food Sales

　　Table 1.1 TOTAL CURRENT VALUE RETAIL SALES BY FOOD AND NON-FOOD，1999-

　　1.2.2 Total Non-food Market： Food/Non-food Sales Split

　　Table 1.2 % BREAKDOWN OF RETAIL SALES BY FOOD AND NON- FOOD， 1999-

　　1.2.3 Total Non-food Market： Urban and Rural Split

　　Table 1.3 TOTAL CURRENT VALUE RETAIL SALES BY FOOD AND NON-FOOD， 1999-

　　1.2.4 Total Non-food Market： Total Value Trends

　　Table 1.4 CURRENT VALUE OF TOTAL RETAIL NON-FOOD SALES BY MAJOR PRODUCT CATEGORY， 1999-

　　1.2.5 Total Non-food Market： Urban Value Trends

　　Table 1.5 URBAN RETAIL NON-FOOD SALES CURRENT VALUE BY MAJOR PRODUCT CATEGORY， 1999-

　　1.2.6 Total Non-food Market： Rural Value Trends

　　Table 1.6 VALUE OF RURAL RETAIL NON-FOOD SALES CURRENT VALUE BY MAJOR PRODUCT CATEGORY， 1999-

　　1.3 China’s Total Pharmaceuticals Market Size

　　1.3.1 Total Market Size： Overall Pharmaceuticals Market Size

　　Table 1.7 ALL PHARMACEUTICALS PRODUCTION IN CHINA BY BROAD SECTOR， 1998-

　　1.3.2 Total Market Size： Prepared Pharmaceuticals Total Market Size

　　Table 1.8 PREPARED PHARMACEUTICALS EXPENDITURE IN CHINA BY BROAD SECTOR， 1998-

　　1.3.3 Total Market Size： Prepared Pharmaceuticals Wholesale Market Size

　　Table 1.9 PREPARED PHARMACEUTICALS WHOLESALE TRADE IN CHINA BY BROAD SECTOR， 1998-

　　1.3.4 Total Market Size： Prepared Pharmaceuticals Retail Market Size

　　Table 1.10 PREPARED PHARMACEUTICALS RETIL SALES IN CHINA BY BROAD SECTOR， 1998-

　　1.4 China’s OTC Pharmaceuticals Market Size

　　1.4.1 OTC Pharmaceuticals Market： Overview

　　1.4.2 OTC Pharmaceuticals Market： Total OTC Market Size

　　Table 1.11 TOTAL MARKET FOR OTC PHARMACEUTICALS IN CHINA， 1998-

　　1.4.3 OTC Pharmaceuticals Market： Non-food Market Significance

　　Table 1.12 THE TOTAL OTC PHARMACEUTICALS MARKET AS A PROPORTION OF TOTAL NON-FOOD RETAIL SALES IN CHINA， 1998-

　　1.4.4 OTC Pharmaceuticals Market： Urban Vs Rural Sales

　　Table 1.13 URBAN VS RURAL SALES OF OTC PHARMACEUTICALS IN CHINA， 1998-

　　1.5 Regional Markets

　　1.5.1 Regional Markets： Provincial Values

　　Table 1.14 VALUE OF OTC PHARMACEUTICALS RETAIL MARKET BY PROVINCE IN CHINA， 1999-

　　1.5.2 Regional Markets： Value Market Growth & Breakdown

　　Table 1.15 % BREAKDOWN & MARKET VALUE GROWTH OF OTC

　　PHARMACEUTICALS RETAIL MARKET BY PROVINCE IN CHINA， 1999-

　　1.5.3 Regional Markets： Per Capita Spending

　　Table 1.16 PER CAPITA RETAIL SPENDING ON OTC PHARMACEUTICALS BY PROVINCE IN CHINA， 1999-

　　1.6 OTC Sector Breakdown

　　1.6.1 Sector Breakdown： Sector Values

　　Table 1.17 VALUE SALES OF OTC PHARMACEUTICALS BY SECTOR IN CHINA， 1998-

　　1.6.2 Sector Breakdown： Sector Shares .

　　Table 1.18 % BREAKDOWN OF OTC PHARMACEUTICALS VALUE SALES BY SECTOR IN CHINA， 1998-

　　1.6.3 Sector Breakdown： Growth Rates

　　Table 1.19 % ANNUAL GROWTH FOR VALUE SALES OF OTC PHARMACEUTICALS BY SECTOR IN CHINA， 1998-

阅读全文：https://www.20087.com/2007-06/R_2007shichangyanjiu114BaoGao.html

　　1.7 Analgesics

　　1.7.1 Analgesics： Subsector Values

　　Table 1.20 MARKET VALUE SALES OF ANALGESICS BY SUBSECTOR IN CHINA， 1998-

　　1.7.2 Analgesics： Value Subsector Shares

　　Table 1.21 % BREAKDOWN OF VALUE SALES OF ANALGES ICS BY SUBSECTOR IN CHINA， 1998-

　　1.7.3 Analgesics： Value Growth Rates

　　Table 1.22 % ANNUAL GROWTH FOR VALUE SALES OF ANALGESICS BY SUBSECTOR IN CHINA， 1998-

　　1.8 Cough， Cold & Allergy Remedies

　　1.8.1 Cough， Cold & Allergy Remedies： Subsector Values

　　Table 1.23 MARKET VALUE SALES OF COUGH， COLD & ALLERGY REMEDIES BY SUBSECTOR IN CHINA， 1998-

　　1.8.2 Cough， Co ld & Allergy Remedies： Value Subsector Shares

　　Table 1.24 % BREAKDOWN OF VALUE SALES OF COUGH， COLD & ALLERGY REMEDIES BY SUBSECTOR IN CHINA， 1998-

　　1.8.3 Cough， Cold & Allergy Remedies： Value Growth Rates

　　Table 1.25 % ANNUAL GROWTH FOR VALUE SALES OF COUGH， COLD & ALLERGY REMEDIES BY SUBSECTOR IN CHINA， 1998-

　　1.9 Digestive Remedies

　　1.9.1 Digestive Remedies： Subsector Values

　　Table 1.26 MARKET VALUE SALES OF DIGESTIVE REMEDIES BY SUBSECTOR IN CHINA， 1998-

　　1.9.2 Digestive Remedies： Value Subsector Shares

　　Table 1.27 % BREAKDOWN OF VALUE SALES OF DIGESTIVE REMEDIES BY SUBSECTOR IN CHINA， 1998-

　　1.9.3 Digestive Remedies： Value Growth Rates

　　Table 1.28 % ANNUAL GROWTH FOR VALUE SALES OF DIGESTIVE REMEDIES BY SUBSECTOR IN CHINA， 1998-

　　1.10 Medicated Skincare

　　1.10.1 Medicated Skincare： Subsector Values

　　Table 1.29 MARKET VALUE SALES OF MEDICATED SKINCARE BY SUBSECTOR IN CHINA， 1998-

　　1.10.2 Medicated Skincare： Value Subsector Shares

　　Table 1.30 % BREAKDOWN OF VALUE SALES OF MEDICATED SKINCARE BY SUBSECTOR IN CHINA， 1998-

　　1.10.3 Medicated Skincare： Value Growth Rates

　　Table 1.31 % ANNUAL GROWTH FOR VALUE SALES OF MEDICATED SKINCARE BY SUBSECTOR IN CHINA， 1998-

　　1.11 Vitamins & Dietary Supplements

　　1.11.1 Vitamins & Dietary Supplements： Subsector Values

　　Table 1.32 MARKET VALUE SALES OF VITAMINS & DIETARY S UPPLEMENTS BY SUBSECTOR IN CHINA， 1998-

　　1.11.2 Vitamins & Dietary Supplements： Value Subsector Shares

　　Table 1.33 % BREAKDOWN OF VALUE SALES OF VITAMINS & DIETARY SUPPLEMENTS BY SUBSECTOR IN CHINA， 1998-

　　1.11.3 Vitamins & Dietary Supplements： Value Growth Rates

　　Table 1.34 % ANNUAL GROWTH FOR VALUE SALES OF VITAMINS & DIETARY SUPPLEMENTS BY SUBSECTOR IN CHINA， 1998-

　　1.12 Other OTC Products

　　1.12.1 Other OTC： Subsector Values

　　Table 1.35 MARKET VALUE SALES OF OTHER OTC PRODUCTS BY SUBSECTOR IN CHINA， 1998-

　　1.12.2 Other OTC： Value Subsector Shares

　　Table 1.36 % BREAKDOWN OF VALUE SALES OF OTHER OTC BY SUBSECTOR IN CHINA， 1998-

　　1.12.3 Other OTC： Value Growth Rates

　　Table 1.37 % ANNUAL GROWTH FOR VALUE SALES OF OTHER OTC BY SUBSECTOR IN CHINA， 1998-

　　1.13 Market Shares

　　1.13.1 Market Shares： Western Medicine Manufacturer Shares

　　Table 1.38 MANUFACTURERS’ SHARES OF RAW PHARMACEUTICAL CHEMICALINDUSTRY REVENUES IN CHINA， 2002/

　　Table 1.39 MANUFACTURERS’ SHARES OF PREPARED PHARMACEUTICALPRODUCTS INDUSTRY REVENUES IN CHINA， 2002/

　　1.13.2 Market Shares： Traditional Chinese Medicine Manufacturer Shares

　　Table 1.40 MANUFACTURERS’ SHARES OF TRADITIONAL CHINESE MEDICINEPHARMACEUTICAL INDUSTRY REVENUES IN CHINA， 2002/

　　1.13.3 Market Shares： Veterinary Medicine Manufacturer Shares

　　Table 1.41 MANUFACTURERS’ SHARES OF VETERINARY PHARMACEUTICALINDUSTRY REVENUES IN CHINA， 2002/

　　1.14 Prices

　　1.14.1 Prices： Retail Price Indices

　　Table 1.42 RETAIL PRICE INDICES BY BROAD SECTOR， 1999-

　　1.15 Outlook

　　1.15.1 Outlook： Forecast Trends

　　1.15.2 Outlook： Forecast Total Market Size

　　Table 1.43 FORECAST ALL PHARMACEUTICALS PRODUCTION IN CHINA BYBROAD SECTOR， 2006-

　　Table 1.44 FORECAST PREPARED PHARMACEUTICALS EXPENDITURE IN CHINABY BROAD SECTOR， 2006-

　　Table 1.45 FORECAST PREPARED PHARMACEUTICALS WHOLESALE TRADE INCHINA BY BROAD SECTOR， 2006-

　　Table 1.46 FORECAST PREPARED PHARMACEUTICALS RETIL SALES IN CHINA BYBROAD SECTOR， 2006-

　　1.15.3 Outlook： Forecast OTC Market Size

　　Table 1.47 FORECAST TOTAL MARKET FOR OTC PHARMACEUTICALS IN CHINA，2006-

　　1.15.4 Outlook： Forecast Sector Values

　　Table 1.48 FORECAST VALUE SALES OF OTC PHARMACEUTICALS BY SECTOR INCHINA， 2006-

　　1.15.5 Outlook： Forecast Sector Percentages

　　Table 1.49 FORECAST % BREAKDOWN OF OTC PHARMACEUTICALS VALUE SALESBY SECTOR IN CHINA， 2006-

　　1.15.6 Outlook： Forecast Sector Annual Growth Rates

　　Table 1.50 FORECAST % ANNUAL GROWTH OF OTC PHARMACEUTICALS VALUESALES BY SECTOR IN CHINA， 2006-

　　1.16 Current Issues

　　1.16.1 Current Issues： Legislation Affecting China’s Pharmaceuticals Industry

　　1.16.2 Current Issues： Definition of Medicines in China

　　1.16.3 Current Issues： Production of Pharmaceuticals in China

　　1.16.4 Current Issues： Pharmaceuticals Licensing in China

　　1.16.5 Current Issues： Pharmaceuticals Industrial Policy in China

　　1.16.6 Current Issues： Pharmaceuticals Licensing in China

　　1.16.7 Current Issues： Pharmaceuticals Packaging in China

　　1.16.8 Current Issues： Regulatory Bodies for the Pharmaceutical Industry in China

　　The Ministry of Public Health

　　The State Pharmaceutical Administration （SPAC）

　　2 MARKETING & DISTRIBUTION

　　2.1 Marketing & Advertising

　　2.1.1 Marketing： Overview

　　2.1.2 Marketing： Pharmaceutical Branding & Advertising

　　2.1.3 Marketing： Pharmaceutical Brand Introduction

　　2.1.4 Marketing： New Opportunities and Latest Developments

　　2.2 Consumers

　　2.2.1 Consumer Profile： Broad Consumer Trends

　　2.2.2 Consumer Profile： OTC Consumers The Elderly Women Children

　　2.3 Wholesale Distribution

　　2.3.1 Wholesale Distribution： Overview

　　2.3.2 Distribution： OTC Distribution

　　2.3.3 The Main Distribution Companies

　　2.3.4 Trends in Retail Sales by Outlet

　　3 CHINA’S HEALTHCARE SERVICES

　　3.1 Historical Overview

2007 China OTC market research report

　　3.2 China’s Healthcare Services： Public Healthcare Policy

　　3.3 China’s Healthcare Services： Healthcare in Rural Areas

　　3.4 China’s Healthcare Services： Chinese Remedies

　　3.5 China’s Healthcare Services： Administrative Agencies

　　3.5.1 Administrative Agencies： State Food and Drug Administration of China （SFDA）

　　3.5.2 Administrative Agencies： The State Development and Reform Commission

　　3.5.3 Administrative Agencies： The Ministry of Commerce

　　3.5.4 Administrative Agencies： The Ministry of Labor and Social Security

　　3.5.5 Administrative Agencies： The Ministry of Health

　　3.5.6 Administrative Agencies： The State Traditional Chinese Medicine Administration.

　　3.5.7 Administrative Agencies： The State Population and Family Planning Commission

　　3.5.8 Administrative Agencies： The Ministry of Science and Technology

　　3.5.9 Administrative Agencies： The State Quality Control Administration

　　3.5.10 Administrative Agencies： Industrial Associations

　　4 SOURCES OF SUPPLY

　　4.1 Domestic Medicine Research & Development

　　4.2 Total Pharmaceutical Industry Size

　　4.2.1 Total Pharmaceutical Industry： Total Industry Manufacturers & Revenue

　　Table 4.1 TOTAL NUMBER OF PHARMACEUTICALS MANUFACTURERS AGAINSTINDUSTRY REVENUES， 1996-2005*

　　4.2.2 Total Pharmaceutical Industry： Total Industry Revenue & Profit

　　Table 4.2 TOTAL PHARMACEUTICALS INSUTRY REVENUE & PROFIT COMPARED，1996-

　　4.2.3 Total Pharmaceutical Industry： Regional Output

　　Table 4.3 REGIONAL STATISTICS OF CHINA’S PHARMACEUTICALSMANUFACTURERS，

　　4.3 Raw Chemical Medicines Industry

　　4.3.1 Raw Chemical Medicines Industry： Total Industry Manufacturers & Revenue

　　Table 4.4 TOTAL NUMBER OF RAW CHEMICAL MEDICINES MANUFACTURERSAGAINST INDUSTRY REVENUES， 1996-2005*

　　4.3.2 Raw Chemical Medicines Industry： Total Industry Revenue & Profit

　　Table 4.5 TOTAL RAW CHEMICAL MEDICINES INSUTRY REVENUE & PROFITCOMPARED， 1996-2005*

　　4.3.3 Raw Chemical Medicines Industry： Regional Output

　　Table 4.6 REGIONAL STATISTICS OF CHINA’S RAW CHEMICAL MEDICINES MANUFACTURERS，

　　4.4 Key Raw Chemical Medicines Manufacturers

　　4.4.1 Key Raw Chemical Medicines Manufacturers： Key Statistics

　　Table 4.7 SUMMARY STATISTICS OF CHINA’S LEADING RAW CHEMICALMEDICINES MANUFACTURERS，

　　Table 4.8 SUMMARY STATISTICS OF CHINA’S LEADING RAW CHEMICALMEDICINES MANUFACTURERS，

　　4.4.2 Key Raw Chemical Medicines Manufacturers： Industry Revenue Shares

　　Table 4.9 CHINA’S LEADING RAW CHEMICAL MEDICINES MANUFACTURERS’ %SHARE OF INDUSTRY REVENUES，

　　Table 4.10 CHINA’S LEADING RAW CHEMICAL MEDICINES MANUFACTURERS’ %SHARE OF INDUSTRY REVENUES，

　　4.4.3 Key Raw Chemical Medicines Manufacturers： Industry Profit Shares

　　Table 4.11 CHINA’S LEADING RAW CHEMICAL MEDICINES MANUFACTURERS’ %SHARE OF INDUSTRY PROFITS，

　　Table 4.12 CHINA’S LEADING RAW CHEMICAL MEDICINES MANUFACTURERS’ %SHARE OF INDUSTRY PROFITS，

　　4.4.4 Key Raw Chemical Medicines Manufacturers： Profitability

　　Table 4.13 CHINA’S LEADING RAW CHEMICAL MEDICINES MANUFACTURERS’PROFITABILITY，

　　Table 4.14 CHINA’S LEADING RAW CHEMICAL MEDICINES MANUFACTURERS’PROFITABILITY，

　　4.4.5 Key Raw Chemical Medicines Manufacturers： Revenue Per Employee

　　Table 4.15 CHINA’S LEADING RAW CHEMICAL MEDICINES MANUFACTURERS’AVERAGE REVENUES PER EMPLOYEE，

　　Table 4.16 CHINA’S LEADING RAW CHEMICAL MEDICINES MANUFACTURERS’AVERAGE REVENUES PER EMPLOYEE，

　　4.5 Prepared Chemical （“Western”） Medicines Industry

　　4.5.1 Prepared Chemical Medicines Industry： Total Industry Manufacturers & Revenue

　　Table 4.17 TOTAL NUMBER OF PREPARED CHEMICAL MEDICINESMANUFACTURERS AGAINST INDUSTRY REVENUES， 1996-2005*

　　4.5.2 Prepared Chemical Medicines Industry： Total Industry Revenue & Profit

　　Table 4.18 TOTAL PREPARED CHEMICAL MEDICINES INSUTRY REVENUE &PROFIT COMPARED， 1996-2005*

　　4.5.3 Prepared Chemical Medicines Industry： Regional Output

　　Table 4.19 REGIONAL STATISTICS OF CHINA’S PREPARED CHEMICAL MEDICINESMANUFACTURERS，

　　4.6 Key Prepared Chemical Me dicines Manufacturers

　　4.6.1 Key Prepared Chemical Medicines Manufacturers： Key Statistics

　　Table 4.20 SUMMARY STATISTICS OF CHINA’S LEADING PREPARED CHEMICALMEDICINES MANUFACTURERS，

　　Table 4.21 SUMMARY STATISTICS OF CHINA’S LEADING PREPARED CHEMICALMEDICINES MANUFACTURERS，

　　4.6.2 Key Prepared Chemical Medicines Manufacturers： Industry Revenue Shares

　　Table 4.22 CHINA’S LEADING PREPARED CHEMICAL MEDICINES

　　MANUFACTURERS’ % SHARE OF INDUSTRY REVENUES，

　　Table 4.23 CHINA’S LEADING PREPARED CHEMICAL MEDICINES

　　MANUFACTURERS’ % SHARE OF INDUSTRY REVENUES，

　　4.6.3 Key Prepared Chemical Medicines Manufacturers： Industry Profit Shares

　　Table 4.24 CHINA’S LEADING PREPARED CHEMICAL MEDICINES

　　MANUFACTURERS’ % SHARE OF INDUSTRY PROFITS，

　　Table 4.25 CHINA’S LEADING PREPARED CHEMICAL MEDICINES

　　MANUFACTURERS’ % SHARE OF INDUSTRY PROFITS，

　　4.6.4 Key Prepared Chemical Medicines Manufacturers： Profitability

　　Table 4.26 CHINA’S LEADING PREPARED CHEMICAL MEDICINES

　　MANUFACTURERS’ PROFITABILITY，

　　Table 4.27 CHINA’S LEADING PREPARED CHEMICAL MEDICINES

　　MANUFACTURERS’ PROFITABILITY，

　　4.6.5 Key Prepared Chemical Medicines Manufacturers： Revenue Per Employee

　　Table 4.28 CHINA’S LEADING PREPARED CHEMICAL MEDICINES

　　MANUFACTURERS’ AVERAGE REVENUES PER EMPLOYEE，

　　Table 4.29 CHINA’S LEADING PREPARED CHEMICAL MEDICINES

　　MANUFACTURERS’ AVERAGE REVENUES PER EMPLOYEE，

　　4.7 Traditional Chinese Medicines Industry

　　4.7.1 Traditional Chinese Medicines Industry： Total Industry Manufacturers & Revenue

　　Table 4.30 TOTAL NUMBER OF TRADITIONAL CHINESE MEDICINES

　　MANUFACTURERS AGAINST INDUSTRY REVENUES， 1996-2005*

　　4.7.2 Traditional Chinese Medicines Industry： Total Industry Revenue & Profit

　　Table 4.31 TOTAL TRADITIONAL CHINESE MEDICINES INSUTRY REVENUE &PROFIT COMPARED， 1996-2005*

　　4.7.3 Traditional Chinese Medicines Industry： Regional Output

　　Table 4.32 REGIONAL STATISTICS OF CHINA’S TRADITIONAL CHINESEMEDICINES MANUFACTURERS，

　　4.8 Key Traditional Chinese Medicines Manufacturers

　　4.8.1 Key Traditional Chinese Medicines Manufacturers： Key Statistics

　　Table 4.33 SUMMARY STATISTICS OF CHINA’S LEADING TRADITIONAL CHINESEMEDICINES MANUFACTURERS，

　　Table 4.34 SUMMARY STATISTICS OF CHINA’S LEADING TRADITIONAL CHINESEMEDICINES MANUFACTURERS，

　　4.8.2 Key Traditional Chinese Medicines Manufacturers： Industry Revenue Shares

　　Table 4.35 CHINA’S LEADING TRADITIONAL CHINESE MEDICINESMANUFACTURERS’ % SHARE OF INDUSTRY REVENUES，

　　Table 4.36 CHINA’S LEADING TRADITIONAL CHINESE MEDICINESMANUFACTURERS’ % SHARE OF INDUSTRY REVENUES，

　　4.8.3 Key Traditional Chinese Medicines Manufacturers： Industry Profit Shares

2007年中國OTC市場研究報告

　　Table 4.37 CHINA’S LEADING TRADITIONAL CHINESE MEDICINESMANUFACTURERS’ % SHARE OF INDUSTRY PROFITS，

　　Table 4.38 CHINA’S LEADING TRADITIONAL CHINESE MEDICINESMANUFACTURERS’ % SHARE OF INDUSTRY PROFITS，

　　4.8.4 Key Traditional Chinese Medicines Manufacturers： Profitability

　　Table 4.39 CHINA’S LEADING TRADITIONAL CHINESE MEDICINESMANUFACTURERS’ PROFITABILITY，

　　Table 4.40 CHINA’S LEADING TRADITIONAL CHINESE MEDICINESMANUFACTURERS’ PROFITABILITY，

　　4.8.5 Key Traditional Chinese Medicines Manufacturers： Revenue Per Employee

　　Table 4.41 CHINA’S LEADING TRADITIONAL CHINESE MEDICINESMANUFACTURERS’ AVERAGE REVENUES PER EMPLOYEE，

　　Table 4.42 CHINA’S LEADING TRADITIONAL CHINESE MEDICINESMANUFACTURERS’ AVERAGE REVENUES PER EMPLOYEE，

　　4.9 Veterinary Medicines Industry

　　4.9.1 Veterinary Medicines Industry： Total Industry Manufacturers & Revenue

　　Table 4.43 TOTAL NUMBER OF VETERINARY MEDICINES MANUFACTURERS

　　AGAINST INDUSTRY REVENUES， 1996-2005*

　　4.9.2 Veterinary Medicines Industry： Total Industry Revenue & Profit

　　Table 4.44 TOTAL VETERINARY MEDICINES INSUTRY REVENUE & PROFITCOMPARED， 1996-2005*

　　4.9.3 Veterinary Medicines Industry： Regional Output

　　Table 4.45 REGIONAL STATISTICS OF CHINA’S VETERINARY MEDICINES MANUFACTURERS，

　　4.10 Key Veterinary Medicines Manufacturers

　　4.10.1 Key Veterinary Medicines Manufacturers： Key Statistics

　　Table 4.46 SUMMARY STATISTICS OF CHINA’S LEADING VETERINARY MEDICINESMANUFACTURERS，

　　Table 4.47 SUMMARY STATISTICS OF CHINA’S LEADING VETERINARY MEDICINESMANUFACTURERS，

　　4.10.2 Key Veterinary Medicines Manufacturers： Industry Revenue Shares

　　Table 4.48 CHINA’S LEADING VETERINARY MEDICINES MANUFACTURERS’ %SHARE OF INDUSTRY REVENUES，

　　Table 4.49 CHINA’S LEADING VETERINARY MEDICINES MANUFACTURERS’ %SHARE OF INDUSTRY REVENUES，

　　4.10.3 Key Veterinary Medicines Manufacturers： Industry Profit Shares

　　Table 4.50 CHINA’S LEADING VETERINARY MEDICINES MANUFACTURERS’ %SHARE OF INDUSTRY PROFITS，

　　Table 4.51 CHINA’S LEADING VETERINARY MEDICINES MANUFACTURERS’ %SHARE OF INDUSTRY PROFITS，

　　4.10.4 Key Veterinary Medicines Manufacturers： Profitability

　　Table 4.52 CHINA’S LEADING VETERINARY MEDICINES MANUFACTURERS’PROFITABILITY，

　　Table 4.53 CHINA’S LEADING VETERINARY MEDICINES MANUFACTURERS’PROFITABILITY，

　　4.10.5 Key Veterinary Medicines Manufacturers： Revenue Per Employee

　　Table 4.54 CHINA’S LEADING VETERINARY MEDICINES MANUFACTURERS’AVERAGE REVENUES PER EMPLOYEE，

　　Table 4.55 CHINA’S LEADING VETERINARY MEDICINES MANUFACTURERS’AVERAGE REVENUES PER EMPLOYEE，

　　5 SWOT ANALYSIS

　　5.1 Strengths

　　5.2 Weaknesses

　　5.3 Opportunities

　　5.4 Threats

　　6 COMPANY PROFILES

　　6.1 Anhui Fengyuan Pharmaceutical Co.， Ltd.

　　6.1.1 Anhui Fengyuan Pharmaceutical： Company Details

　　6.1.2 Anhui Fengyuan Pharmaceutical： Company Background

　　6.1.3 Anhui Fengyuan Pharmaceutical： Financial Results

　　Table 6.1 ANHUI FENGYUAN PHARMACEUTICAL CO.， IAL RESULTS，2003-

　　6.2 Astrazeneca （Wuxi） Pharmaceutical Co.， Ltd.

　　6.2.1 Astrazeneca （Wuxi） Pharmaceutical： Company Details

　　6.2.2 Astrazeneca （Wuxi） Pharmaceutical： Financial Results

　　Table 6.2 ASTRAZENECA （WUXI） PHARMACEUTICAL CO.， LTD.： FINANCIALRESULTS，

　　6.3 Bayer AG

　　6.3.1 Bayer： Company Details

　　6.3.2 Bayer： Company Background

　　6.3.3 Bayer： Financial Results

　　Table 6.3 BAYER AG.： FINANCIAL RESULTS， 2003-

　　6.4 Beijing Double Crane Pharmaceutical Co.， Ltd.

　　6.4.1 Beijing Double Crane Pharmaceutical： Company Details

　　6.4.2 Beijing Double Crane Pharmaceutical： Company Background

　　6.4.3 Beijing Double Crane Pharmaceutical： Financial Results

　　Table 6.4 BEIJING DOUBLE CRANE PHARMACEUTICAL CO.， LTD.： FINANCIALRESULTS， 2003-

　　6.5 Beijing SL Pharmaceutical Co.， Ltd.

　　6.5.1 Beijing SL Pharmaceutical： Company Details

　　6.5.2 Beijing SL Pharmaceutical： Company Background

　　6.5.3 Beijing SL Pharmaceutical： Financial Results

　　Table 6.5 BEIJING SL PHARMACEUTICAL CO.， LTD.： FINANCIAL RESULTS， 2003-

　　6.6 Beijing Tiantan Biological Products Corp. Ltd.

　　6.6.1 Beijing Tiantan Biological Products： Company Details

　　6.6.2 Beijing Tiantan Biological Products： Company Background

　　6.6.3 Beijing Tiantan Biological Products： Financial Results

　　Table 6.6 BEIJING TIANTAN BIOLOGICAL PRODUCTS CORP.， LTD.： FINANCIALRESULTS， 2003-

　　6.7 Beijing Tongrentang Co.， Ltd

　　6.7.1 Beijing Tongrentang： Comp any Details

　　6.7.2 Beijing Tongrentang： Company Background

　　6.7.3 Beijing Tongrentang： Financial Results

　　Table 6.7 BEIJING TONGRENTANG CO.， LTD.： FINANCIAL RESULTS， 2003-

　　6.8 Chengdu Hoist Inc. Ltd.

　　6.8.1 Chengdu Hoist： Company Details

　　6.8.2 Chengdu Hoist： Company Background

　　6.8.3 Chengdu Hoist： Financial Results

　　Table 6.8 CHENGDU HOIST CO.， LTD.： FINANCIAL RESULTS， 2003-

　　6.9 Chengzhi Co.， Ltd.

　　6.9.1 Chengzhi： Company Details

　　6.9.2 Chengzhi： Company Background

　　6.9.3 Chengzhi： Financial Results

　　Table 6.9 CHENGZHI CO.， LTD.： FINANCIAL RESULTS， 2003-

　　6.10 Chiatai Qingchunbao Pharmaceutical Co.， Ltd.

　　6.10.1 Chiatai Qingchunbao Pharmaceutical： Company Details

　　6.10.2 Chiatai Qingchunbao Pharmaceutical： Financial Results

　　Table 6.10 CHIATAI QINGCHUNBAO PHARMACEUTICAL CO.， LTD.： FINANCIALRESULTS， 2002/

　　6.11 China National Medicines Corp. Ltd.

　　6.11.1 China National Medicines： Company Details

　　6.11.2 China National Medicines： Company Background

　　6.11.3 China National Medicines： Financial Results

　　Table 6.11 CHINA NATIONAL MEDICINES CO.， LTD.： FINANCIAL RESULTS， 2003-

　　6.12 Chongqing Huapont Pharmaceutical Co.， Ltd.

　　6.12.1 Chongqing Huapont Pharmaceutical： Company Details

　　6.12.2 Chongqing Huapont Pharmaceutical： Company Background

2007 nián zhōngguó otc shìchǎng yán jiù bàogào

　　6.12.3 Chongqing Huapont Pharmaceutical： Financial Results

　　Table 6.12 CHONGQING HUAPONT PHARMACEUTICAL CO.， LTD.： FINANCIALRESULTS， 2003-

　　6.13 Chongqing Taiji Industry （Group） Co.， Ltd.

　　6.13.1 Chongqing Taiji Industry Group： Company Details

　　6.13.2 Chongqing Taiji Industry Group： Company Background

　　6.13.3 Chongqing Taiji Industry Group： Financial Results

　　Table 6.13 CHONGQING TAIJI INDUSTRY GROUP CO.， LTD.： FINANCIAL RESULTS，2003-

　　6.14 Chongqing Three Gorges Stock Group Co.， Ltd.

　　6.14.1 Chongqing Three Gorges Stock Group： Company Details

　　6.14.2 Chongqing Three Gorges Stock Group： Financial Results

　　Table 6.14 CHONGQING THREE GORGES STOCK GROUP CO.， LTD.： FINANCIALRESULTS，

　　6.15 Chongqing Tongjunge Co.， Ltd.

　　6.15.1 Chongqing Tongjunge： Company Details

　　6.15.2 Chongqing Tongjunge： Company Background

　　6.15.3 Chongqing Tongjunge： Financial Results

　　Table 6.15 CHONGQING TONGJUNGE CO.， LTD.： FINANCIAL RESULTS， 2003-

　　6.16 Dalian Merro Pharmaceutical Co.， Ltd

　　6.16.1 Dalian Merro Pharmaceutical： Company Details

　　6.16.2 Dalian Merro Pharmaceutical： Company Background

　　6.16.3 Dalian Merro Pharmaceutical： Financial Results

　　Table 6.16 DALIAN MERRO PHARMACEUTICAL CO.， LTD.： FINANCIAL RESULTS，2003-

　　6.17 Guangdong Kangmei Pharmaceutical Co.， Ltd.

　　6.17.1 Guangdong Kangmei Pharmaceutical： Company Details

　　6.17.2 Guangdong Kangmei Pharmaceutical： Company Background

　　6.17.3 Guangdong Kangmei Pharmaceutical： Financial Results

　　Table 6.17 GUANGDONG KANGMEI PHARMACEUTICAL CO.， LTD.： FINANCIALRESULTS， 2003-

　　6.18 Guangxi Beisheng Pharmaceutical Co.， Ltd.

　　6.18.1 Guangxi Beisheng Pharmaceutical： Company Details

　　6.18.2 Guangxi Beisheng Pharmaceutical： Company Background

　　6.18.3 Guangxi Beisheng Pharmaceutical： Financial Results

　　Table 6.18 GUANGXI BEISHENG PHARMACEUTICAL CO.， LTD.： FINANCIALRESULTS， 2003-

　　6.19 Guangzhou Baiyunshan Pharmaceutical Stock Co.， Ltd.

　　6.19.1 Guangzhou Baiyunshan Pharmaceutical： Company Details

　　6.19.2 Guangzhou Baiyunshan Pharmaceutical： Company Background

　　6.19.3 Guangzhou Baiyunshan Pharmaceutical： Financial Results

　　Table 6.19 GUANGZHOU BAIYUNSHAN PHARMACEUTICAL CO.， LTD.： FINANCIALRESULTS， 2004/

　　6.20 Guangzhou Pharmaceutical Co.， Ltd.

　　6.20.1 Guangzhou Pharmaceutical： Company Details

　　6.20.2 Guangzhou Pharmaceutical： Company Background

　　6.20.3 Guangzhou Pharmaceutical： Financial Results

　　Table 6.20 GUANGZHOU PHARMACEUTICAL CO.， LTD.： FINANCIAL RESULTS， 2003-

　　6.21 Guilin Jiqi Pharmaceutical Co.， Ltd.

　　6.21.1 Guilin Jiqi Pharmaceutical： Company Details

　　6.21.2 Guilin Jiqi Pharmaceutical： Company Background

　　6.21.3 Guilin Jiqi Pharmaceutical： Financial Results

　　Table 6.21 GUILIN JIQI PHARMACEUTICAL CO.， LTD.： FINANCIAL RESULTS， 2003-

　　6.22 Guizhou Yibai Pharmaceutical Co.， Ltd.

　　6.22.1 Guizhou Yibai Pharmaceutical： Company Details

　　6.22.2 Guizhou Yibai Pharmaceutical： Company Background

　　6.22.3 Guizhou Yibai Pharmaceutical： Financial Results

　　Table 6.22 GUIZHOU YIBAI PHARMACEUTICAL CO.， LTD.： FINANCIAL RESULTS，2003-

　　6.23 Hainan Haiyao Co.， Ltd.

　　6.23.1 Hainan Haiyao： Company Details

　　6.23.2 Hainan Haiyao： Company Background

　　6.23.3 Hainan Haiyao： Financial Results

　　Table 6.23 HAINAN HAIYAO CO.， LTD.： FINANCIAL RESULTS， 2003-

　　6.24 Hangzhou Tianmushan Pharmaceutical Co.， Ltd.

　　6.24.1 Hangzhou Tianmushan Pharmaceutical： Company Details

　　6.24.2 Hangzhou Tianmushan Pharmaceutical： Company Background

　　6.24.3 Hangzhou Tianmushan Pharmaceutical： Financial Results

　　Table 6.24 HANGZHOU TIANMUSHAN PHARMACEUTICAL CO.， LTD.： FINANCIALRESULTS， 2003-

　　6.25 Harbin Pharmaceutical Group Holding Co.， Ltd.

　　6.25.1 Harbin Pharmaceutical Group： Company Details

　　6.25.2 Harbin Pharmaceutical Group： Company Background

　　Company History

　　Company Key Sectors

　　Company Structure

　　6.25.3 Harbin Pharmaceutical Group： Financial Results

　　Table 6.25 HARBIN PHARMACEUTICAL GROUP CO.， LTD.： FINANCIAL RESULTS，2003-

　　6.26 Harbin Pharmaceutical Group Sanjing Pharmaceutical Co.， Ltd

　　6.26.1 Harbin Pharmaceutical Group Sanjing Pharmaceutical： Company Details

　　6.26.2 Harbin Pharmaceutical Group Sanjing Pharmaceutical： Company Background

　　6.26.3 Harbin Pharmaceutical Group Sanjing Pharmaceutical： Financial Results

　　Table 6.26 HARBIN PHARMACEUTICAL GROUP SANJING PHARMACEUTICAL CO.，LTD.： FINANCIAL RESULTS， 2003-

　　6.27 Henan Joyline & Joysun Pharmaceutical Co.， Ltd.

　　6.27.1 Henan Joyline & Joysun Pharmaceutical： Company Details

　　6.27.2 Henan Joyline & Joysun Pharmaceutical： Company Background

　　6.27.3 Henan Joyline & Joysun Pharmaceutical： Financial Results

　　Table 6.28 HENAN JOYLINE & JOYS UN PHARMACEUTICAL CO.， LTD.： FINANCIALRESULTS， 2003-

　　6.28 Henan Lingrui Pharmaceutical Co.， Ltd.

　　6.28.1 Henan Lingrui Pharmaceutical： Company Details

　　6.28.2 Henan Lingrui Pharmaceutical： Company Background

　　6.28.3 Henan Lingrui Pharmaceutical： Financial Results

　　Table 6.28 HENAN LINGRUI PHARMACEUTICAL CO.， LTD.： FINANCIAL RESULTS，2003-

　　6.29 Henan Topfond Pharmaceutical Co.， Ltd.

　　6.29.1 Henan Topfond Pharmaceutical： Company Details

　　6.29.2 Henan Topfond Pharmaceutical： Company Background

　　6.29.3 Henan Topfond Pharmaceutical： Financial Results

　　Table 6.29 HENAN TOPFOND PHARMACEUTICAL CO.， LTD.： FINANCIAL RESULTS，2003-

　　6.30 Hengdian Group Tospo Pharmaceutical Co.， Ltd.

　　6.30.1 Hengdian Group Tospo Pharmaceutical： Company Details

　　6.30.2 Hengdian Group Tospo Pharmaceutical： Financial Results

　　Table 6.30 HENGDIAN GROUP TOSPO PHARMACEUTICAL CO.， LTD.： FINANCIALRESULTS， 2003-

　　6.31 Huadong Medicine Co.， Ltd

2007年の中国のOTC市場調査レポート

　　6.31.1 Huadong Medicine： Company Details

　　6.31.2 Huadong Medicine： Company Background

　　6.31.3 Huadong Medicine： Financial Results

　　Table 6.31 HUADONG MEDICINE CO.， LTD.： FINANCIAL RESULTS， 2003-

　　6.32 Hualan Biological Engineering Inc.

　　6.32.1 Hualan Biological Engineering： Company Details

　　6.32.2 Hualan Biological Engineering： Company Background

　　6.32.3 Hualan Biological Engineering： Financial Results

　　Table 6.32 HUALAN BIOLOGICAL ENGINEERING CO.， LTD.： FINANCIAL RESULTS，2003-

　　6.33 Hubei Biocause Pharmaceutical Co.， Ltd.

　　6.33.1 Hubei Biocause Pharmaceutical： Company Details

　　6.33.2 Hubei Biocause Pharmaceutical： Company Background

　　6.33.3 Hubei Biocause Pharmaceutical： Financial Results

　　Table 6.33 HUBEI BIOCAUSE PHARMACEUTICAL CO.， LTD.： FINANCIAL RESULTS，2003-

　　6.34 Hubei Guangji Pharmaceutical Co.， Ltd.

　　6.34.1 Hubei Guangji Pharmaceutical： Company Details

　　6.34.2 Hubei Guangji Pharmaceutical： Company Background

　　6.34.3 Hubei Guangji Pharmaceutical： Financial Results

　　Table 6.34 HUBEI GUANGJI PHARMACEUTICAL CO.， LTD.： FINANCIAL RESULTS，2003-

　　6.35 Hubei Qiangjiang Pharmaceutical Co.， Ltd.

　　6.35.1 Hubei Qiangjiang Pharmaceutical： Company Details

　　6.35.2 Hubei Qiangjiang Pharmaceutical： Company Background

　　6.35.3 Hubei Qiangjiang Pharmaceutical： Financial Results

　　Table 6.35 HUBEI QIANGJIANG PHARMACEUTICAL CO.， LTD.： FINANCIALRESULTS， 2003-

　　6.36 Inner Mongolia Biological Pharmaceutical Factory

　　6.36.1 Inner Mongolia Biological Pharmaceutical Factory： Company Details

　　6.36.2 Inner Mongolia Biological Pharmaceutical Factory： Financial Results

　　Table 6.36 INNER MONGOLIA BIOLOGICAL PHARMACEUTICAL FACTORY CO.，LTD.： FINANCIAL RESULTS， 2003-

　　6.37 Jiangsu Hengrui Medicine Co.， Ltd

　　6.37.1 Jiangsu Hengrui Medicine： Company Details

　　6.37.2 Jiangsu Hengrui Medicine： Company Background

　　6.37.3 Jiangsu Hengrui Medicine： Financial Results

　　Table 6.37 JIANGSU HENGRUI MEDICINE CO.， LTD.： FINANCIAL RESULTS， 2003-

　　6.38 Jiangsu Kanion Pharmaceutical Co.， Ltd.

　　6.38.1 Jiangsu Kanion Pharmaceutical： Company Details

　　6.38.2 Jiangsu Kanion Pharmaceutical： Company Background

　　6.38.3 Jiangsu Kanion Pharmaceutical： Financial Results

　　Table 6.38 JIANGSU KANION PHARMACEUTICAL CO.， LTD.： FINANCIAL RESULTS，2003-

　　6.39 Jiangsu Lianhuan Pharmaceutical Co.， Ltd

　　6.39.1 Jiangsu Lianhuan Pharmaceutical： Company Details

　　6.39.2 Jiangsu Lianhuan Pharmaceutical： Company Background

　　6.39.3 Jiangsu Lianhuan Pharmaceutical： Financial Results

　　Table 6.39 JIANGSU LIANHUAN PHARMACEUTICAL CO.， LTD.： FINANCIALRESULTS， 2003-

　　6.40 Jiangsu Sihuan Bio-Engineering Co.， Ltd.

　　6.40.1 Jiangsu Sihuan Bio-Engineering： Company Details

　　6.40.2 Jiangsu Sihuan Bio-Engineering： Company Background

　　6.40.3 Jiangsu Sihuan Bio-Engineering： Financial Results

　　Table 6.40 JIANGSU SIHUAN BIO-ENGINEERING CO.， LTD.： FINANCIAL RESULTS，2003-

　　6.41 Jiangsu Yangzi River Pharmaceutical Group Co

相
关
报
告

	中国OTC市场研究分析与发展趋势预测报告（2024-2030年）优惠价：7200元
	中国OTC产业市场深度研究分析报告（2024年版）优惠价：7200元

1 2 下一页 »

2007年中国OTC市场研究报告

网上订购　　下载协议　　下载简版

订阅《2007年中国OTC市场研究报告》，编号：0237850
请拨打：400-612-8668、010-66181099、66182099、66183099　Email：Kf@20087.com

OTC行业发展趋势 2007年中国OTC市场研究报告

2007年中国OTC市场研究报告

内容介绍：

二维码

订阅流程

浏览记录

合作客户

相关报告

近期更新

2007年中国OTC市场研究报告 OTC市场前景分析